MedCity Influencers

St. Jude Medical to close $1.3B AGA Medical buy today

St. Jude Medical Inc. (NYSE:STJ) concluded its tender offer AGA Medical Holdings Inc. (NASDAQ:AGAM) and expects to close its $1.03 billion acquisition of the rival cardiovascular device maker today.

St. Jude Medical Inc. (NYSE:STJ) concluded its tender offer AGA Medical Holdings Inc. (NASDAQ:AGAM) and expects to close its $1.03 billion acquisition of the rival cardiovascular device maker today.

The St. Paul, Minnesota-based company said about 91.1 percent of AGA’s outstanding stock was tendered as part of its buyout of the company, and another 6.7 percent of AGA stock was tendered by notices of guaranteed delivery.

St. Jude said it calculated the exchange rate by dividing $20.80 by $38.54, which is the volume weighted average of the daily closing prices of STJ stock for the 10 trading days that ending Nov. 15, the second trading day prior to its planned expiration date for the exchange offer. The company said it conducted the deal with a so-called “a short-form merger” through its subsidiary Asteroid Subsidiary Corp.

The acquisition agreement stipulated that each AGAM shareholder receive $10.40 in cash and $10.40 worth of STJ stock. The agreement was based on AGAM’s average closing price during the 10 trading days ending two days before St. Jude began buying up AGAM shares on Oct. 20, according to St. Jude’s announcement of the merger.

Plymouth, Minnesota-based AGA develops devices used to repair structural heart defects and treat vascular diseases. The company will be subsumed by St. Jude’s cardiovascular unit, which makes vascular closure and heart valve products.

STJ shares closed at $39.31, up 2.1 percent for the day. AGAM shares closed at $21.20, up 2.2 percent.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.